Search Results for: GENE CELL THERAPY Its Growing
Articles
AAV VECTOR MANUFACTURING - Challenges & Opportunities in the Manufacturing of AAV Vectors Used in the Delivery of Gene Therapy Treatments February 28, 2017
Daniel C. Smith, PhD, indicates there remains a clear need for improved process productivities, and the need to develop manufacturing processes that can be applied to a wide number of AAV-based viral vector therapeutic candidates.
Caladrius Subsidiary, PCT, to Manufacture Phase III Cell Therapy Product for Kiadis Pharma June 27, 2016
Caladrius Biosciences, Inc. recently announced that PCT has expanded its relationship with Kiadis Pharma by entering into an agreement for...Cobra Biologics & Touchlight Collaborate on Production of Next-Generation DNA Constructs June 14, 2016
Cobra Biologics Ltd and Touchlight are collaborating on a project to optimize the manufacture of Adeno-Associated Virus (AAV) vectors used...MilliporeSigma Builds on Leading Viral & Gene Therapy Service Offering May 9, 2016
MilliporeSigma recently announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products. ...Inovio Partners With National Cancer Institute & Mayo Clinic to Initiate Hepatitis C Immunotherapy Clinical Trial May 2, 2016
Inovio Pharmaceuticals, Inc. recently announced its immunotherapy for hepatitis C (INO-8000) will be evaluated in a Phase I trial in...Pluristem Continues to Strengthen its Position in Japan; Granted Two Key April 17, 2016
Pluristem Therapeutics Inc. recently announced that the Japan Patent Office has granted the Company two key patents addressing: 1) Pluristem’s...IMMUNOTHERAPY RESEARCH - The Shift Toward Combination Therapies March 30, 2016
Jean Pierre Wery, PhD, indicates immunotherapy in combination with traditional treatments has the potential for becoming a more effective alternative to the current standard of care. These types of combination therapies are currently under investigation and appear to have synergistic effects compared to the use of one therapy alone.
Inovio Pharmaceuticals Acquires Needle-Free Injection Technology to Advance Strategy for Next-Generation Vaccines March 18, 2016
Inovio Pharmaceuticals, Inc. recently announced it has signed a definitive agreement to acquire all of Bioject Medical Technologies Inc.’s assets,...GeneOne Life Science & Inovio Pharmaceuticals to Collaborate on Zika Virus Vaccine Development January 26, 2016
GeneOne Life Science recently announced the initiation of a collaborative research program with Inovio Pharmaceuticals to test and advance a...STEM CELL MARKET - Stem Cell Therapy to Redefine Regenerative Medicine November 18, 2015
Jane C. Andrews, PhD, Frost & Sullivan Analyst, says faced with increasing challenges, such as costly treatments and treatments that are palliative rather than symptomatic, the global healthcare industry today is gradually transforming itself. With few existing therapies capable of curing or significantly changing the course of a disease, healthcare providers are starting to look toward regenerative medicine as a viable alternative.
Celgene to Acquire Receptos, Advances Leadership in Immune-Inflammatory Diseases July 16, 2015
Celgene Corporation and Receptos, Inc. recently announced the signing of a definitive agreement in which Celgene has agreed to acquire...New Mechanism for Engineering Genetic Traits Governed by Multiple Genes Paves Way for Various Advances March 18, 2015
When it comes to gene expression, scientists have so far studied one single gene at a time. A new approach...Stem Cell Therapies Gathering Momentum But Significant Challenges Remain December 9, 2014
LONDON, UK (GlobalData), 9 December 2014 - With 104 programs in late-stage clinical development, the stem cell therapy space could...Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells April 7, 2014
A ground-breaking study spearheaded by Scientific Director Giulio Superti-Furga at the CeMM Research Center for Molecular Medicine of the Austrian...CELL THERAPIES - The Challenges & Possible Solutions for Transferring Cell Therapy From the Bench to the Industry March 6, 2014
Lior Raviv, MMedSc, and Ohad Karnieli, PhD, discuss the significant emerging challenges in downstream processing of cell therapies focused mostly on allogeneic therapies.
Baxter International & Cell Therapeutics Announce Worldwide Strategic Collaboration November 19, 2013
Baxter International Inc. and Cell Therapeutics, Inc. recently announced they have entered into an exclusive worldwide licensing agreement to develop...ThermoGenesis & TotipotentRx Form $18.6-Million Agreement July 31, 2013
ThermoGenesis Corp. and TotipotentRx Corporation recently announced they have entered into a definitive merger agreement. The combined company is expected...Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism May 7, 2024
Lantern Pharma Inc. recently announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics, to optimize the development of its...SPECIAL FEATURE - Prefilled Syringes & Parenteral Delivery: Next-Gen Injections Feature Technology & Reconstitution April 30, 2024
Contributor Cindy H. Dubin highlights innovations from key players in parenteral delivery and prefilled syringes, with focuses on safety, meeting regulatory requirements, cost, fill/finish, and dosing.
4BIO Capital Portfolio Company Ascend Acquires Florida-Based GMP Manufacturing Capacity April 9, 2024
Long-Term Partnership Agreed with Beacon Therapeutics for Clinical and Commercial AAV Production….
